Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SchiFT: Praziquantel for Schistosomiasis Related Hepatic Fibrosis
NCT07754617Phase 3Not yet recruiting
- Sponsor
- Rhode Island Hospital
- Start
- Nov 2026
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
A Phase 3 trial of praziquantel in schistosomiasis, Liver Fibrosis (LF), sponsored by Rhode Island Hospital. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
praziquantel
03
Conditions
schistosomiasisLiver Fibrosis (LF)
Beyond the preview
Go deeper on NCT07754617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07754617.